Strengthening protection of intellectual property rights (IPR) is crucial to attracting investment in Taiwan’s pharmaceutical sector. In order to better protect IPR for innovative products, the Pharmaceutical Committee of the American Chamber of Commerce in Taipei recommends completing the legislative process for Patent Linkage and Data Exclusivity. Patent Linkage prevents regulatory authorization of generic medicines…

“Robust intellectual property (IP) protection is vital for biopharmaceutical innovation,” stresses a recently released report from Geneva Network, a UK-based public policy research and advocacy organization specializing in international intellectual property, health, and trade issues. The report – written by Geneva Network researcher Jack Ellis, a former Asia-Pacific editor of Intellectual Asset Management magazine –…

A visiting delegation urges early passage of Patent Linkage legislation. During a recent visit to Taipei, a six-member delegation from the Washington, DC-based Pharmaceutical Research and Manufacturers of America (PhRMA) urged Taiwan’s legislature to give early attention to pending bills to strengthen intellectual property protection for pharmaceuticals. Passage of the proposed amendments to the Pharmaceutical…

A National Drug Policy Forum brought wide discussion but few conclusions. The Ministry of Health and Welfare (MOHW) in early February convened a one-day National Drug Policy Forum (originally scheduled to be held in December 2014), bringing together representatives from the various stakeholders: government, hospitals and other healthcare providers, the pharmaceutical industry (both originals and…

animal cosmetic testing white mice

How to protect animals while also ensuring consumer safety? A bill currently before the Legislative Yuan would prohibit the manufacture and sale in Taiwan of cosmetics products tested on animals when alternative methods are available. It would authorize the Taiwan Food and Drug Administration (TFDA) to designate the alternative methods specified for industry use. If…